0 TSX Venture News - May 9, 2024Inventronics Announces 2024 Q1 Financial ResultsCALGARY, Alberta, May 09, 2024 (GLOBE NEWSWIRE) — Inventronics Limited (“Corporation”) (IVX:TSX Venture), a designer and manufacturer of enclosures for […]Read More
0 TSX Venture News - May 9, 2024Nova Leap Health Corp. Posts Q1 2024 ResultsNOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, May 09, 2024 […]Read More
0 NYSE Companies - May 9, 2024Osisko Development Provides Corporate UpdatesMONTREAL, May 09, 2024 (GLOBE NEWSWIRE) — Osisko Development Corp. (NYSE: ODV, TSXV: ODV) (“Osisko Development” or the “Company“) announces […]Read More
0 NYSE Companies - May 9, 2024Osisko Announces the Voting Results From Its Annual Meeting of ShareholdersMONTREAL, May 09, 2024 (GLOBE NEWSWIRE) — Osisko Gold Royalties Ltd (the “Corporation” or “Osisko”) (OR: TSX & NYSE) announces […]Read More
0 NASDAQ Companies - May 9, 2024BankFinancial Corporation Reports Financial Results for the First Quarter 2024BURR RIDGE, Ill., May 09, 2024 (GLOBE NEWSWIRE) — BankFinancial Corporation (Nasdaq – BFIN) (“BankFinancial”) filed its Quarterly Report on Form […]Read More
0 NYSE Companies - May 9, 2024ADC Therapeutics nimmt an der RBC Capital Markets Global Healthcare Conference 2024 teilLAUSANNE, Schweiz, May 09, 2024 (GLOBE NEWSWIRE) — ADC Therapeutics SA (NYSE: ADCT) gab heute bekannt, dass Ameet Mallik, Chief […]Read More
0 NASDAQ Companies - May 9, 2024vTv Therapeutics Announces 2024 First Quarter Financial Results and Provides Corporate UpdateHIGH POINT, N.C., May 09, 2024 (GLOBE NEWSWIRE) — vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused […]Read More
0 NASDAQ Companies - May 9, 202423andMe to Report Q4 and Full Year FY2024 Financial ResultsSOUTH SAN FRANCISCO, Calif., May 09, 2024 (GLOBE NEWSWIRE) — 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics […]Read More
0 NASDAQ Companies - May 9, 2024Innospec Reports First Quarter 2024 Financial ResultsStrong contribution from Performance Chemicals drives operating income growth of 23 percent $80.6 million cash generated from operations; Net cash […]Read More
0 NASDAQ Companies - May 9, 2024Arvinas Announces Upcoming Vepdegestrant Poster Presentations at the 2024 European Society for Medical Oncology (ESMO) Breast Cancer Annual CongressNEW HAVEN, Conn., May 09, 2024 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN) today announced that two posters, including updated […]Read More